EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Relevance of Next-Generation Sequencing in the Diagnosis of Thalassemia and Hemoglobinopathies: The Experience of Four Italian Diagnostic Hubs

Rita Selvatici iD, Valentina Guida iD, Massimo Maffei iD, Milena Agata Irrera, Alice Margutti iD, Paola Bisceglia iD, Massimo Mogni, Erica Melchionda, Giuseppina Stoico, Nicoletta Grifone, Laura Bocciardo, Simone Salerio iD und 8 weitere

Genes · 2024

DOI: 10.3390/genes16010028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, 2024. Verfasst von Rita Selvatici und 19 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Medical Genetics, Department of Medical Sciences, University Hospital S. Anna Ferrara, 44121 Ferrara, Italy. Hauptthemen laut MEDLINE: High-Throughput Nucleotide Sequencing, Hemoglobinopathies, Thalassemia. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of Health (Current Research funds).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Thalassemias and hemoglobinopathies are among the most common genetic diseases worldwide and have a significant impact on public health. The decreasing cost of next-generation sequencing (NGS) has quickly enabled the development of new assays that allow for the simultaneous analysis of small nucleotide variants (SNVs) and copy number variants (CNVs) as deletions/duplications of α- and β-globin genes. Background/Objectives: This study highlighted the efficacy and rapid identification of all types of mutations in the α- and β-globin genes, including silent variants, using the Devyser Thalassemia NGS kit. Furthermore, we report the frequency of mutations identified in a total population of 2649 individuals recruited from four Italian Medical Genetics Laboratories.

Methods

All samples were first hematologically characterized, and sequence analysis was conducted by using the Devyser Thalassemia NGS kit. All variants were also validated in an independent sample by a conventional molecular test.

Results

A total of 1789 subjects were identified with genetic variants in the globin genes, of which 966 (53.9%) had variations in the β-gene, 480 (26.8%) had variations in the α-gene; and 307 (17.1%) had variations in both α- and β-genes. Variant analysis evidenced a heterogeneous mutation spectrum enriched with variants not usually observed in the Italian population.

Conclusions

This study showed the high effectiveness and the rapid identification of all mutation types in both α- and β-globin genes, including silent variants. It should be emphasized that the NGS approach greatly shortens turnaround reporting times, overcoming the classic diagnostic flowchart which envisages multistep, subsequent, diagnostic approaches, often requiring long resolution times.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

High-Throughput Nucleotide SequencingHemoglobinopathiesThalassemiaHumansItalybeta-GlobinsMalealpha-GlobinsFemaleMutationDNA Copy Number VariationsAdultMiddle AgedChildAdolescent

Stichwörter der Autor:innen

hemoglobinopathiesnext-generation sequencing approachthalassemias

Substanzen

beta-Globinsalpha-Globins

Autor:innen und Institutionen

  • Unit of Medical Genetics, Department of Medical Sciences, University Hospital S. Anna Ferrara, 44121 Ferrara, Italy.
  • Unit of Medical Genetics, Department of Mother and Child, University Hospital S. Anna Ferrara, 44121 Ferrara, Italy.
  • Division of Medical Genetics, Fondazione IRCCS-Casa Sollievo della Sofferenza, 71013 San Giovanni Rotondo, Italy.
  • Laboratory of Human Genetics, IRCCS Istituto Giannina Gaslini, 16147 Genoa, Italy.
  • Laboratory of Medical Genetics, Clinical Pathology UOC, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.

ORCID-Profile: Rita Selvatici, Valentina Guida, Massimo Maffei, Alice Margutti, Paola Bisceglia, Simone Salerio, Alessandro De Luca, Alessandra Ferlini, Domenico Coviello, Cristina Curcio

Förderung

  • Italian Ministry of Health (Current Research funds)

Zitieren

APA

Selvatici, R., Guida, V., Maffei, M., Irrera, M. A., Margutti, A., Bisceglia, P., Mogni, M., Melchionda, E., Stoico, G., Grifone, N., Bocciardo, L., Salerio, S., Nagliati, V., Alberico, A., Tringali, G., Melles, C., De Luca, A., Ferlini, A., Coviello, D., & Curcio, C. (2024). Relevance of Next-Generation Sequencing in the Diagnosis of Thalassemia and Hemoglobinopathies: The Experience of Four Italian Diagnostic Hubs. Genes. https://doi.org/10.3390/genes16010028

Vancouver

Selvatici R, Guida V, Maffei M, Irrera MA, Margutti A, Bisceglia P, et al. Relevance of Next-Generation Sequencing in the Diagnosis of Thalassemia and Hemoglobinopathies: The Experience of Four Italian Diagnostic Hubs. Genes. 2024. doi:10.3390/genes16010028

BibTeX
@article{Selvatici2024,
  author = {Selvatici, Rita and Guida, Valentina and Maffei, Massimo and Irrera, Milena Agata and Margutti, Alice and Bisceglia, Paola and Mogni, Massimo and Melchionda, Erica and Stoico, Giuseppina and Grifone, Nicoletta and Bocciardo, Laura and Salerio, Simone and Nagliati, Vittoria and Alberico, Angela and Tringali, Giusy and Melles, Cristina and De Luca, Alessandro and Ferlini, Alessandra and Coviello, Domenico and Curcio, Cristina},
  title = {Relevance of Next-Generation Sequencing in the Diagnosis of Thalassemia and Hemoglobinopathies: The Experience of Four Italian Diagnostic Hubs},
  journal = {Genes},
  year = {2024},
  doi = {10.3390/genes16010028}
}
Kostenlos starten →